166 related articles for article (PubMed ID: 30386121)
1. Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D.
Konstantinides P; Alexopoulou A; Hadziyannis E; Kanellopoulou T; Dourakis SP
Ann Gastroenterol; 2018; 31(6):705-711. PubMed ID: 30386121
[TBL] [Abstract][Full Text] [Related]
2. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.
Lake-Bakaar G; Jacobson I; Talal A
Clin Exp Immunol; 2012 Nov; 170(2):231-7. PubMed ID: 23039894
[TBL] [Abstract][Full Text] [Related]
3. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A
Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059
[TBL] [Abstract][Full Text] [Related]
4. Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.
Kong F; Zhang W; Feng B; Zhang H; Rao H; Wang J; Cong X; Wei L
Virol J; 2015 Jul; 12():100. PubMed ID: 26129991
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India.
Behera MK; Shukla SK; Dixit VK; Nath P; Abhilash VB; Asati PK; Jain AK
Indian J Med Res; 2018 Aug; 148(2):200-206. PubMed ID: 30381543
[TBL] [Abstract][Full Text] [Related]
6. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
[TBL] [Abstract][Full Text] [Related]
7. Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.
Fan XH; Wu CH; Wang LF; Zheng YY; Yao Y; Lu HY; Xu XY; Wei L
Chin Med J (Engl); 2012 Nov; 125(22):4014-7. PubMed ID: 23158135
[TBL] [Abstract][Full Text] [Related]
8. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
Ogurtsov PP; Kukhareva EI
Klin Med (Mosk); 2016; 94(3):224-30. PubMed ID: 27522730
[TBL] [Abstract][Full Text] [Related]
9. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
Petta S; Cammà C; Scazzone C; Tripodo C; Di Marco V; Bono A; Cabibi D; Licata G; Porcasi R; Marchesini G; Craxí A
Hepatology; 2010 Apr; 51(4):1158-67. PubMed ID: 20162613
[TBL] [Abstract][Full Text] [Related]
10. [The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia].
Fan XH; Wu CH; Zheng YY; Wang LF; Huo N; Shao CP; Lu HY; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):429-33. PubMed ID: 24034843
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.
Petta S; Ferraro D; Cammà C; Cabibi D; Di Cristina A; Di Marco V; Di Stefano R; Grimaudo S; Mazzola A; Levrero M; Scazzone C; Craxì A
Antivir Ther; 2012; 17(5):823-31. PubMed ID: 22505587
[TBL] [Abstract][Full Text] [Related]
12. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
Ayad MW; Elbanna AA; Elneily DA; Sakr AS
Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
14. Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis.
Mou H; Yang F; Zhou J; Bao C
Exp Ther Med; 2018 Nov; 16(5):4082-4088. PubMed ID: 30344685
[TBL] [Abstract][Full Text] [Related]
15. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
de Carvalho JTG; Schneider M; Cuppari L; Grabulosa CC; Cendoroglo M; Dalboni MA
J Ren Nutr; 2019 Sep; 29(5):454-461. PubMed ID: 30686751
[TBL] [Abstract][Full Text] [Related]
17. Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
Tohra SK; Taneja S; Ghosh S; Sharma BK; Duseja A; Dhiman RK; Das A; Chawla YK
Dig Dis Sci; 2011 Aug; 56(8):2449-55. PubMed ID: 21706207
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum Interleukin-33 concentration before and after treatment with pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1b infection.
Cacopardo B; Rita Pinzone M; Palermo F; Nunnari G
Hepat Mon; 2012 Dec; 12(12):e7611. PubMed ID: 23423835
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.
Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH
Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin.
Ueyama M; Nakagawa M; Sakamoto N; Onozuka I; Funaoka Y; Watanabe T; Nitta S; Kiyohashi K; Kitazume A; Murakawa M; Nishimura-Sakurai Y; Sekine-Osajima Y; Itsui Y; Azuma S; Kakinuma S; Watanabe M;
Antivir Ther; 2011; 16(7):1081-91. PubMed ID: 22024524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
